It has been shown that the increase in the acute phase immune response factor, stimulated by interleukin 6 (IL-6), can rise not only during the acute phase of stroke but also in response to a broad spectrum of systemic inflammatory conditions [12]. This evidence concerns the gene IL6 and stroke disorder.